CERVICAL CANCER RECURRENT
Clinical trials for CERVICAL CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCER RECURRENT trials appear
Sign up with your email to follow new studies for CERVICAL CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Large study tests new drug combinations for advanced cervical cancer
Disease control Not yet recruitingThis study aims to observe the safety and effectiveness of treatments involving the drugs camrelizumab or famitinib for women with recurrent or metastatic cervical cancer. It will follow about 1,300 patients who have already decided to receive one of these treatments as part of t…
Matched conditions: CERVICAL CANCER RECURRENT
Sponsor: Qi Zhou • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug combo trial seeks better tolerability for Tough-to-Treat cervical cancer
Disease control Not yet recruitingThis study is testing if using a lower dose of the drug famitinib, when combined with another drug called camrelizumab, can reduce side effects while still controlling cancer growth. It will involve 120 women with cervical cancer that has returned or spread and is no longer curab…
Matched conditions: CERVICAL CANCER RECURRENT
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC